CC
ALXN

Carlson Capital’s Alexion Pharmaceuticals ALXN Stock Holding History

Carlson Capital’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-679,150
Closed -$125M – 222
2021
Q2 		$125M Buy
679,150
+65,759
+11% +$11.3M 6.03% 3
2021
Q1 		$93.8M Buy
613,391
+128,391
+26% +$19.9M 3.5% 5
2020
Q4 		$75.8M Buy
+485,000
New +$62.3M 2.71% 8
2017
Q3 		– Sell
-114,697
Closed -$14M – 287
2017
Q2 		$14M Sell
114,697
-259,803
-69% -$30.2M 0.2% 159
2017
Q1 		$45.4M Buy
374,500
+269,883
+258% +$34.8M 0.58% 53
2016
Q4 		$12.8M Buy
+104,617
New +$12.8M 0.15% 163
2015
Q3 		– Sell
-71,484
Closed -$12.9M – 383
2015
Q2 		$12.9M Buy
+71,484
New +$12.3M 0.14% 189

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return